Xianmin Mu
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Oncology
- Complementary and alternative medicine top 5%
- Co-authors
- Qiang YouTing ZhaoJinshun PanBiao GengChao WangChe XuJiajia ShenWei Shi
- Topics
- Cancer, Hypoxia, and Metabolism (4 papers)Natural Compounds in Disease Treatment (4 papers)Drug-Induced Hepatotoxicity and Protection (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaHepatology
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Xianmin Mu
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 707
- Cancer Research 413
- Immunology 333
- Oncology 178
- Complementary and alternative medicine 93
Countries citing papers authored by Xianmin Mu
This map shows the geographic impact of Xianmin Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianmin Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianmin Mu more than expected).
Fields of papers citing papers by Xianmin Mu
This network shows the impact of papers produced by Xianmin Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianmin Mu. The network helps show where Xianmin Mu may publish in the future.
Co-authorship network of co-authors of Xianmin Mu
This figure shows the co-authorship network connecting the top 25 collaborators of Xianmin Mu. A scholar is included among the top collaborators of Xianmin Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianmin Mu. Xianmin Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 15 | |
| 7 | 93 | |
| 8 | 8 | |
| 9 | 6 | |
| 10 | 87 | |
| 11 | 109 | |
| 12 | 4 | |
| 13 | 86 | |
| 14 | 10 | |
| 15 | 96 | |
| 16 | 7 | |
| 17 | 2 | |
| 18 | 16 | |
| 19 | 9 | |
| 20 | 47 |
About Xianmin Mu
Xianmin Mu is a scholar working on Complementary and alternative medicine, Cancer Research and Hepatology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Natural Compounds in Disease Treatment (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Cancer Research (413 citations), Immunology (333 citations) and Geriatrics and Gerontology (45 citations). Xianmin Mu has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Qiang You, Ting Zhao, Jinshun Pan, Biao Geng, Chao Wang, Che Xu, Jiajia Shen, Wei Shi, Jing Yang and Hao Wen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.